BioCorp and Roche Diabetes Care France announced the launch of the Mallya smart insulin pen device in France.
Developed by BioCorp, Mallya is an intelligent sensor for insulin injection pens that has CE mark approval in Europe. The platform is compatible with any disposable insulin pen. It enables reliable monitoring for doses selected for injection and it offers patients with diabetes better compliance with their treatment, according to the companies.
Get the full story at our sister site, Drug Delivery Business News.